Venter
Producer: Krka Slovenia
Code of automatic telephone exchange: A02BX02
Release form: Firm dosage forms. Tablets.
General characteristics. Structure:
Active ingredient: 500 mg of a sukralfat.
Excipients: starch corn, magnesium stearate. talc, aerosil (silicon dioxide colloid).
Pharmacological properties:
Pharmacodynamics. Gastroprotektivny means. Entering interaction with proteins of nekrotizirovanny edge of an ulcer, drug creates a blanket which prevents the further destroying effect of pepsin, hydrochloric acid and salts of bile acids. Venter inhibits activity of pepsin for 30%. Has slight antiacid effect. Besides, drug stimulates products of slime, bicarbonates, regeneration of cells of a mucous membrane of a stomach that increases its resistance to action of internal and exogenous pathogenic causes.
Indications to use:
- a peptic ulcer of a stomach and/or duodenum in an aggravation stage;
- a hyperphosphatemia at the patients with uraemia who are on a hemodialysis.
Route of administration and doses:
Venter appoint 1 g 4 times a day or on 2 g 2 times a day for 1 h to food and before going to bed. Maximum daily dose of drug of 8 g.
The average duration of a course of treatment makes 4-6 weeks, if necessary - up to 12 weeks.
Features of use:
With care appoint drug to patients with the expressed abnormal liver functions.
Side effects:
Seldom: nausea, lock, headache.
Interaction with other medicines:
At co-administration of Venter and tetracycline delay of absorption of the last is possible.
The concomitant use of the drugs which are slowing down release of hydrochloric acid in a stomach leads to decrease in efficiency of Venter. In case of need the drugs which are slowing down release of hydrochloric acid should be accepted, at least, in 30-60 min. prior to Venter's reception.
Contraindications:
- pregnancy;
- children's age up to 4 years;
- the expressed renal failures;
- bleedings from a GIT;
- hypersensitivity to drug.
Storage conditions:
List B. In the dry, protected from light place, at a temperature not above 25 °C. To store in the place, unavailable to children. Not to use after the period of validity specified on packaging. A period of validity - 3 years.
Issue conditions:
According to the recipe
Packaging:
Tablets of 500 mg. On 10 or 20 tablets in a blister strip packaging. 10 blister strip packagings on 10 tablets or 5 blister strip packagings on 20 tablets together with the application instruction place in a pack from a cardboard.